App-Quantinova.ai

A simple classification of systemic sclerosis using subset and autoantibodies can discriminate well between distinct outcome groups

Svetlana I Nihtyanova - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Patients with systemic sclerosis can identify with distinct symptom patterns of Raynaud’s phenomenon that are associated with different physician and patient-reported assessments of disease severity

John Pauling - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Raynaud syndrome

N/A

A study examining the reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: challenges and insights for future clinical trial design

Michael Hughes - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

BILAG2004-Pregnancy index is sensitive to change

Chee-Seng Yee - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Exploring a biopsychosocial approach to pain in adolescents and young adults with juvenile idiopathic arthritis (young investigator award winner 2018)

Hema Chaplin - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

N/A

Describing current UK practice in assessment and management of juvenile localised scleroderma and consideration in context of PRES working party recommendations

Hanna Lythgoe - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Scleroderma

N/A

Diederik De Cock - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Infliximab

Impact evaluation of an online training on the Strengthening And Stretching for Rheumatoid Arthritis of the Hand (SARAH) programme recommended in the NICE guidelines for rheumatoid arthritis

Cynthia Srikesavan - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Cana clinical pharmacist-led gout clinic help patients achieve target serum uric acid levels?

Jane Whiteman - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout

N/A

Online booking for a nurse helpline significantly improves patients’ access to advice

Laura Blackler - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

G-Protein-coupled receptor-65 expression marks out a pathogenic GM-CSF-producing subset of CD4 T cells which are expanded in spondyloarthritis

Hussein Al-Mossawi - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Spondyloarthritis

GM-CSF

Predisposition of RA monocytes/macrophages to a pro-inflammatory phenotype through down-regulation of mitochondrial translocator protein

Nehal Narayan - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Glucocorticoid

A novel scoring system using hand/feet radiographs to differentiate psoriatic arthritis from osteoarthritis

Sardar Bahadur - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Psoriatic arthritis

N/A

Return of the king: rising incidence of gout in England 2006-2017 (Young investigator award winner 2018)

Mark D Russell - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout

N/A

What shall we tell the children? How families manage and talk about parental rheumatic disease

Elizabeth D P Hale - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Hydroxychloroquine use, risk of retinal toxicity, and potential impact of screening in a large tertiary centre

Mark Yates - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

Hydroxychloroquine

A lymphoid pathotype at baseline, in early inflammatory arthritis, significantly associates with requirement for biologic therapy at 12 months follow up: results from the pathobiology of early arthritis cohort

Gloria Lliso Ribera - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Early inflammatory arthritis

N/A

Change in function, fatigue and pain in anti-CCP positive at-risk individuals predict progression to inflammatory arthritis

Sarah Twigg - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Implantable loop recorder in systemic sclerosis over three years confirms incidental significant arrhythmia and suggests CMR and cardiac biomarker association

Raluca B Dumitru - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Interleukin 31 promotes pathogenic mechanisms in scleroderma and induces skin fibrosis in mice

Nikita Arumalla - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

Interleukin

Filters

45280 Abstracts